Imagine: forgetfulness and cognitive decline are no longer a sentence! Scientists have developed a nasal spray that has already shown remarkable results in experiments on mice, opening doors to a new era of brain rejuvenation.
The human lifespan is steadily increasing, but this progress is accompanied by a troubling rise in cases of dementia. It seems that in the past, people simply did not live long enough to develop such conditions. Analysis of postmortem brain samples has revealed that acquired dementia often correlates with inflammatory processes in the hippocampus, a key area for learning and memory.
"Moderate chronic neuroinflammation is significantly heightened in individuals suffering from neurodegenerative diseases," the article published in the Journal of Extracellular Vesicles notes. Over time, this persistent inflammation destroys brain cells, exacerbates oxidative stress, and disrupts mitochondrial function, the internal "power stations" of each cell.
It is crucial to halt the inflammatory process before it causes irreversible damage. However, a serious question arises: how to deliver medication directly to the brain while avoiding invasive surgical interventions?
Taking a large number of pills is ineffective, as our brain is securely protected by the blood-brain barrier, which blocks the penetration of most substances. Researchers from Texas A&M University, after extensive research, discovered that a nasal spray could be the ideal solution for bypassing this protection.
This delivery method has shown remarkable effectiveness: the active substance reaches the brain just six hours after application. To combat inflammation, scientists proposed using microscopic vesicles that are naturally released by stem cells of the nervous system and serve for intercellular communication.
Inside these bubbles are special molecules that are believed to actively reduce inflammatory responses and comprehensively support the health of brain cells.
Breakthrough Trials on Mice
To test the effectiveness of the new development, the nasal spray was tested on laboratory mice. For the experiment, rodents were selected whose age was equivalent to about 60 human years. Some animals received two doses of the drug through the nose with a two-week interval, while the control group received a placebo.
A month after the final injection, all animals underwent a series of memory tests. The researchers then carefully examined the changes that occurred in the brain tissues of the rodents.
The results of this experiment were quite encouraging: the mice receiving the nasal spray showed a significant reduction in brain cell swelling caused by inflammation. Chemical damage was noticeably less pronounced, while the brain's natural defense systems, on the contrary, were activated.
Importantly, the genes responsible for cellular energy production demonstrated increased activity. This directly indicates that the drug successfully restored the metabolic functions of the aging brain.
In memory tests, the rodents that underwent the therapy showed truly impressive results. They effortlessly recognized previously seen objects and instantly identified their locations, indicating excellent hippocampal function.
